Concepedia

Author

MD Rawlins

Newcastle University

Also Known As

MD Rawlins

11

Publications

391

Citations

8

H-Index

31

Concepts

All Affiliations

Newcastle University
MR

About

MD Rawlins is an author at Newcastle University specializing in clinical safety, patient safety, and drug safety.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

239

2

Health Policy

3

3

239

3

Health Sciences

1

1

22

4

Public Health

1

1

187

5

Emergency Medicine

1

1

187

MD Rawlins

×

6

Publications

362

Citations

6

H-Index

YearCitations

Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom [see comments]

KJ Belton, Sarah Payne, MD Rawlins,

British Journal of Clinical Pharmacology

1995

187

Determinants of plasma alpha 1‐acid glycoprotein (AAG) concentrations in health.

PG Blain, JC Mucklow, MD Rawlins,

British Journal of Clinical Pharmacology

1985

79

Guidelines for company‐sponsored Safety Assessment of Marketed Medicines (SAMM) guidelines. Medicines Control Agency, Committee on Safety of Medicines, Royal College of General Practitioners, British Medical Association and Association of the British Pharmaceutical Industry (November 1993) [see comments]

P.J. Waller, SM Wood, AM Breckenridge,

British Journal of Clinical Pharmacology

1994

30

Review of yellow cards (1986): report to the Committee on the Safety of Medicines.

JL Bem, AM Breckenridge, RD Mann,

British Journal of Clinical Pharmacology

1988

23

United Kingdom Product Licence applications involving new active substances, 1987‐1989: their fate after appeals.

MD Rawlins, D.B. Jefferys

British Journal of Clinical Pharmacology

1993

22

The effects of intradermal bradykinin are potentiated by angiotensin converting enzyme inhibitors in hypertensive patients.

R E Ferner, David I. Wilson, J R Paterson,

British Journal of Clinical Pharmacology

1989

21

Page 1